From: 2D-shear wave elastography: number of acquisitions can be reduced according to clinical setting
N = 452 | |
---|---|
Age (years) ± SD (missing N = 29) | 49.0 ± 13.5 |
Gender M/F (missing N = 18) | 282(65%)/152(35%) |
BMI (kg/m2) ± SD (missing N = 201) | 26.3 ± 5.6 |
< 25 kg/m2 | 115 (46%) |
25–29.9 kg/m2 | 81 (32%) |
≥ 30 kg/m2 | 55 (22%) |
ALD | 62 (14%) |
HBV | 108 (24%) |
HCV | 116 (26%) |
NAFLD | 69 (15%) |
Other | 97 (21%) |
2D-SWE registration—Biopsy delay (days) median (IQR) | 0 (0; 2) |
Mean LS of three 2D-SWE measures (kPa) median (IQR) | 9 (6.8; 21.4) |
Fibrosis stage | |
F0 | 72 (15.9%) |
F1 | 103 (22.8%) |
F2 | 72 (15.9%) |
F3 | 54 (12.0%) |
F4 | 151 (33.4%) |
Steatosis grade (missing N = 149) | |
S0 | 140 (46%) |
S1 | 82 (27%) |
S2 | 60 (20%) |
S3 | 21 (7%) |
AST (IU/L) (missing N = 55) median (IQR) | 48 (32; 69) |
ALT (IU/L) (missing N = 36) median (IQR) | 52 (32; 85) |
Total bilirubin (µmol/L) (missing N = 48) median (IQR) | 13 (8.6; 23.9) |